[HTML][HTML] Diagnostic accuracy of different machine learning algorithms for breast cancer risk calculation: a meta-analysis

RD Nindrea, T Aryandono, L Lazuardi… - Asian Pacific journal of …, 2018 - ncbi.nlm.nih.gov
Objective The aim of this study was to determine the diagnostic accuracy of different
machine learning algorithms for breast cancer risk calculation. Methods A meta-analysis …

Breast cancer complexity: implications of intratumoral heterogeneity in clinical management

B Haynes, A Sarma, P Nangia-Makker… - Cancer and Metastasis …, 2017 - Springer
Generation of intratumoral phenotypic and genetic heterogeneity has been attributed to
clonal evolution and cancer stem cells that together give rise to a tumor with complex …

[HTML][HTML] Breast cancer risk from modifiable and non-modifiable risk factors among women in Southeast Asia: a meta-analysis

RD Nindrea, T Aryandono… - Asian Pacific journal of …, 2017 - ncbi.nlm.nih.gov
Objective: The aim of this study was to determine breast cancer risk from modifiable and non-
modifiable factors among women in Southeast Asia. Methods: This meta-analysis was …

Age at diagnosis predicted survival outcome of female patients with breast cancer at a tertiary hospital in Yogyakarta, Indonesia

ES Sinaga, RA Ahmad, S Shivalli… - Pan African Medical …, 2018 - ajol.info
Introduction: breast cancer is the most common cancer in women in Indonesia. Patients'
survival depends on various factors, namely patient-, tumor-, and treatment-related factors …

Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions

B Brahma, T Yamamoto - European Journal of Surgical Oncology, 2019 - Elsevier
Breast cancer is the most common cancer in Dharmais hospital. The treatment can give rise
to breast cancer treatment-related lymphedema (BCRL) that will cause significant …

Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis

SM Khoirunnisa, FDA Suryanegara, D Setiawan… - Plos one, 2024 - journals.plos.org
Background Trastuzumab has significantly enhanced the survival and prognosis of
individuals diagnosed with human epidermal growth factor receptor 2 (HER2)-positive early …

[HTML][HTML] Association of BRCA1 Promoter methylation with breast cancer in Asia: a meta-analysis

RD Nindrea, WA Harahap, T Aryandono… - Asian Pacific journal of …, 2018 - ncbi.nlm.nih.gov
Objective: The aim of this study was to determine the degree of association of BRCA1
promoter methylation with breast cancer in Asia. Methods: The study sample for the present …

[HTML][HTML] Family history of breast cancer and breast cancer risk between Malays ethnicity in Malaysia and Indonesia: A Meta-Analysis

RD Nindrea, T Aryandono, L Lazuardi… - Iranian journal of …, 2019 - ncbi.nlm.nih.gov
Background: Breast cancer is the most common cancer type in women not only in world but
also in Malays ethnicity between Malaysia and Indonesia. Breast cancer has varying …

Six months vs. 12 months of adjuvant trastuzumab among women with HER2-positive early-stage breast cancer: A meta-analysis of randomized controlled trials

H Deng, X Du, L Wang, M Chen - Frontiers in oncology, 2020 - frontiersin.org
Purpose: Both 12 and 6 months of trastuzumab in combination with chemotherapy are
effective for HER2+ early-stage breast cancer. This meta-analysis was performed to assess …

[PDF][PDF] The effect of logotherapy on depression in breast cancer patients under chemotherapy

SB Putri, M Jannah - Breast cancer, 2019 - wjrr.org
Background: Chemotherapy is the treatment most often carried out by breast cancer patients
with psychological side effects are stress. Logotherapy is one therapy that can be used as a …